FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367394778> ?p ?o ?g. }

• W4367394778 abstract "Abstract Patients with inflammatory bowel disease (IBD) treated with biologic and/or immunosuppressant drugs are at increased risk for opportunistic infections. Seroprevalence studies can confirm the diagnosis of SARS-CoV-2 infections as well as the associated risk factors. This is a descriptive study which primary endpoints were to highlight the prevalence of SARS-CoV-2 antibodies in a cohort of IBD patients in March 2021, and to analyze seroconversion in patients with known COVID-19 infection and its relationship with IBD treatments. Patients filled in a questionnaire about symptoms of COVID-19 infection and clinical information about their IBD. All included patients were tested for SARS-CoV-2 antibodies. 392 patients were included. Among patients with clinical infection, 69 patients (17,65%) were IgG-positive, 286 (73,15%) IgG-negative and 36 (9,21%) indeterminate. In relation to seroconversion among patients under biologic treatment, 13 patients of the 23 with a previous positive CRP developed antibodies (56.5%). However, when the influence of immunosuppressive treatment on the probability of developing antibodies was analyzed, no significant differences were seen between those patients with or without treatment (77.8% vs. 77.1%, p = 0.96). In our cohort of IBD patients, after one year of pandemic, there were 18.64% IgG positive patients, a higher prevalence than the general population (15.7%)." @default.
• W4367394778 created "2023-04-30" @default.
• W4367394778 creator A5004218838 @default.
• W4367394778 creator A5009560263 @default.
• W4367394778 creator A5021116736 @default.
• W4367394778 creator A5022454431 @default.
• W4367394778 creator A5038451847 @default.
• W4367394778 creator A5039841792 @default.
• W4367394778 creator A5043396998 @default.
• W4367394778 creator A5050881392 @default.
• W4367394778 creator A5055504491 @default.
• W4367394778 creator A5059496061 @default.
• W4367394778 creator A5078897839 @default.
• W4367394778 creator A5086223785 @default.
• W4367394778 date "2023-04-29" @default.
• W4367394778 modified "2023-10-17" @default.
• W4367394778 title "Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease" @default.
• W4367394778 cites W2016685455 @default.
• W4367394778 cites W2084584045 @default.
• W4367394778 cites W2087544958 @default.
• W4367394778 cites W2131198668 @default.
• W4367394778 cites W2604846773 @default.
• W4367394778 cites W2970843227 @default.
• W4367394778 cites W3009335299 @default.
• W4367394778 cites W3015190630 @default.
• W4367394778 cites W3015718611 @default.
• W4367394778 cites W3015728842 @default.
• W4367394778 cites W3017731458 @default.
• W4367394778 cites W3021590963 @default.
• W4367394778 cites W3023428589 @default.
• W4367394778 cites W3024177957 @default.
• W4367394778 cites W3024972049 @default.
• W4367394778 cites W3033022675 @default.
• W4367394778 cites W3040552450 @default.
• W4367394778 cites W3041106228 @default.
• W4367394778 cites W3045809269 @default.
• W4367394778 cites W3093656234 @default.
• W4367394778 cites W3145175338 @default.
• W4367394778 cites W3145876243 @default.
• W4367394778 cites W4288443557 @default.
• W4367394778 doi "https://doi.org/10.1038/s41598-023-33402-w" @default.
• W4367394778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37120662" @default.
• W4367394778 hasPublicationYear "2023" @default.
• W4367394778 type Work @default.
• W4367394778 citedByCount "0" @default.
• W4367394778 crossrefType "journal-article" @default.
• W4367394778 hasAuthorship W4367394778A5004218838 @default.
• W4367394778 hasAuthorship W4367394778A5009560263 @default.
• W4367394778 hasAuthorship W4367394778A5021116736 @default.
• W4367394778 hasAuthorship W4367394778A5022454431 @default.
• W4367394778 hasAuthorship W4367394778A5038451847 @default.
• W4367394778 hasAuthorship W4367394778A5039841792 @default.
• W4367394778 hasAuthorship W4367394778A5043396998 @default.
• W4367394778 hasAuthorship W4367394778A5050881392 @default.
• W4367394778 hasAuthorship W4367394778A5055504491 @default.
• W4367394778 hasAuthorship W4367394778A5059496061 @default.
• W4367394778 hasAuthorship W4367394778A5078897839 @default.
• W4367394778 hasAuthorship W4367394778A5086223785 @default.
• W4367394778 hasBestOaLocation W43673947781 @default.
• W4367394778 hasConcept C126322002 @default.
• W4367394778 hasConcept C159654299 @default.
• W4367394778 hasConcept C201903717 @default.
• W4367394778 hasConcept C203014093 @default.
• W4367394778 hasConcept C2777451964 @default.
• W4367394778 hasConcept C2778260677 @default.
• W4367394778 hasConcept C2778494684 @default.
• W4367394778 hasConcept C2779134260 @default.
• W4367394778 hasConcept C2908647359 @default.
• W4367394778 hasConcept C45189115 @default.
• W4367394778 hasConcept C71924100 @default.
• W4367394778 hasConcept C72563966 @default.
• W4367394778 hasConcept C99454951 @default.
• W4367394778 hasConceptScore W4367394778C126322002 @default.
• W4367394778 hasConceptScore W4367394778C159654299 @default.
• W4367394778 hasConceptScore W4367394778C201903717 @default.
• W4367394778 hasConceptScore W4367394778C203014093 @default.
• W4367394778 hasConceptScore W4367394778C2777451964 @default.
• W4367394778 hasConceptScore W4367394778C2778260677 @default.
• W4367394778 hasConceptScore W4367394778C2778494684 @default.
• W4367394778 hasConceptScore W4367394778C2779134260 @default.
• W4367394778 hasConceptScore W4367394778C2908647359 @default.
• W4367394778 hasConceptScore W4367394778C45189115 @default.
• W4367394778 hasConceptScore W4367394778C71924100 @default.
• W4367394778 hasConceptScore W4367394778C72563966 @default.
• W4367394778 hasConceptScore W4367394778C99454951 @default.
• W4367394778 hasIssue "1" @default.
• W4367394778 hasLocation W43673947781 @default.
• W4367394778 hasLocation W43673947782 @default.
• W4367394778 hasLocation W43673947783 @default.
• W4367394778 hasLocation W43673947784 @default.
• W4367394778 hasOpenAccess W4367394778 @default.
• W4367394778 hasPrimaryLocation W43673947781 @default.
• W4367394778 hasRelatedWork W1977869253 @default.
• W4367394778 hasRelatedWork W2062254869 @default.
• W4367394778 hasRelatedWork W2066497741 @default.
• W4367394778 hasRelatedWork W2098265647 @default.
• W4367394778 hasRelatedWork W2138179989 @default.
• W4367394778 hasRelatedWork W2182978221 @default.
• W4367394778 hasRelatedWork W2320301988 @default.
• W4367394778 hasRelatedWork W2352883426 @default.

• next